Chemical Structure : GDC-0810
CAS No.: 1365888-06-7
货号: PC-43264Not For Human Use, Lab Use Only.
GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation), binds to ERα and ERβ with with Ki of 3.8 and 3.7 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg (Free Sample) | ¥280 | In stock | |
10 mg | ¥1480 | In stock | |
25 mg | ¥2580 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation), binds to ERα and ERβ with with Ki of 3.8 and 3.7 nM, respectively.
GDC-0810 dually antagonizes and induces proteasome-dependent degradation of ERα.
GDC-0810 exhibits robust in vitro activity against a variety of human breast cancer cell lines (MCF7 cell IC50=25 nM).
GDC-0810 demonstrates robust activity in models of tamoxifen-sensitive and tamoxifen-resistant breast cancer models.
分子量 | 446.9006 | |
分子式 | C26H20ClFN2O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 30 mg/mL |
|
Chemical Name/SMILES |
2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)- |
1. Lai A, et al. J Med Chem. 2015 Jun 25;58(12):4888-904.
2. Joseph JD, et al. Elife. 2016 Jul 13;5. pii: e15828.
3. Wang Y, et al. Clin Cancer Res. 2017 Jun 15;23(12):3053-3060.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright